Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Jon C. Ogg | Nov 22, 2011 at 8:29 AM EST

Top Analyst Upgrades & Downgrades (AMGN, AN, BXP, CREE, DOLE, GRMN, GILD, HIG, HAR, MSFT, NFLX, VRUS, TSN, WYNN, YUM)

These are some of Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Amgen Inc. (NASDAQ: AMGN)…

Paul Ausick | Nov 21, 2011 at 4:08 PM EST

24/7 Wall St. Closing Bell (AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN, HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z)

Stock prices plunged this morning and spent most of the day trading way down. The DJIA hovered around -300 points…

Mike Sauter | Nov 21, 2011 at 8:57 AM EST

Top Active Trader Alert Stocks (GILD, RIMM, VRUS)

Crude oil is at $96.43, down 1.29% Gold is at $1,766, down 0.74%. Hong Kong’s Hang Seng closed down 1.44%…

Jon C. Ogg | Nov 21, 2011 at 7:51 AM EST

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Gilead Sciences Inc. (NASDAQ: GILD) is trading lower on news that it is spending some $11 billion to buy Pharmasset,…

Jon C. Ogg | Oct 19, 2011 at 11:34 AM EDT

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

We have compiled a detailed list of expected upside in the biotech sector. The sector has consolidated and now there…

Jon C. Ogg | Sep 16, 2011 at 8:07 AM EDT

Top Analyst Upgrades & Downgrades (ADTN, AGN, AAPL, ADP, ABX, C, EXPE, GILD, LNKD, MA, NOK, OPEN, PWRD, RIMM, RGLD, TSM, AMTD, VECO)

Jon OggThese are some of this Friday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Jun 29, 2011 at 8:04 AM EDT

Top Analyst Upgrades & Downgrades (AKS, ARMH, CMG, C, GILD, GS, KFT, MPEL, PVA, RIMM, SMP, X)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday…

Jon C. Ogg | Jun 12, 2011 at 9:40 AM EDT

Key Stocks To Watch This Coming Week, The Unusual Suspects (ADP, CSX, FVE, GILD, LYV, LULU, RMBS, REGN, RIMM, SIRI, P, SIX, VRX)

The upcoming week is not very active on the earnings front but we do have some key events to watch…

Douglas A. McIntyre | Apr 23, 2011 at 8:54 AM EDT

The Week’s Largest Market Losers

Iron Mountain’s proxy fight with Elliott Management continued, as the company added an Elliott board member and said it may…

Jon C. Ogg | Apr 11, 2011 at 2:01 PM EDT

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Biotech is becoming the ever-shrinking stock sector. It is almost weekly now that a new biotech acquisition is announced. Big Pharma in…

Jon C. Ogg | Mar 2, 2011 at 12:44 PM EST

Dividends For Biotech? (AMGN, GILD)

Investors love huge biotech opportunities for growth. Investors also love to get paid in the form of dividends. Unfortunately, the…

Jon C. Ogg | Dec 29, 2010 at 1:47 PM EST

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks,…

Jon C. Ogg | Dec 10, 2010 at 8:13 AM EST

Top Analyst Upgrades and Downgrades (ARG, IRE, BRCM, CPN, CELG, CIT, DRYS, GILD, INTC, LULU, MRVL, NVDA, PG, QCOM, RIMM, TXN)

These are some of this Friday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Airgas Inc.…

Jon C. Ogg | Nov 6, 2010 at 12:07 PM EDT

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may…

Jon C. Ogg | Sep 9, 2010 at 1:57 PM EDT

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there…

1 … 44 45 46 47 48 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades & Downgrades (AMGN, AN, BXP, CREE, DOLE, GRMN, GILD, HIG, HAR, MSFT, NFLX, VRUS, TSN, WYNN, YUM)

24/7 Wall St. Closing Bell (AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN, HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z)

Top Active Trader Alert Stocks (GILD, RIMM, VRUS)

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

Top Analyst Upgrades & Downgrades (ADTN, AGN, AAPL, ADP, ABX, C, EXPE, GILD, LNKD, MA, NOK, OPEN, PWRD, RIMM, RGLD, TSM, AMTD, VECO)

Top Analyst Upgrades & Downgrades (AKS, ARMH, CMG, C, GILD, GS, KFT, MPEL, PVA, RIMM, SMP, X)

Key Stocks To Watch This Coming Week, The Unusual Suspects (ADP, CSX, FVE, GILD, LYV, LULU, RMBS, REGN, RIMM, SIRI, P, SIX, VRX)

The Week’s Largest Market Losers

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividends For Biotech? (AMGN, GILD)

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

Top Analyst Upgrades and Downgrades (ARG, IRE, BRCM, CPN, CELG, CIT, DRYS, GILD, INTC, LULU, MRVL, NVDA, PG, QCOM, RIMM, TXN)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades & Downgrades (AMGN, AN, BXP, CREE, DOLE, GRMN, GILD, HIG, HAR, MSFT, NFLX, VRUS, TSN, WYNN, YUM)

24/7 Wall St. Closing Bell (AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN, HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z)

Top Active Trader Alert Stocks (GILD, RIMM, VRUS)

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

Top Analyst Upgrades & Downgrades (ADTN, AGN, AAPL, ADP, ABX, C, EXPE, GILD, LNKD, MA, NOK, OPEN, PWRD, RIMM, RGLD, TSM, AMTD, VECO)

Top Analyst Upgrades & Downgrades (AKS, ARMH, CMG, C, GILD, GS, KFT, MPEL, PVA, RIMM, SMP, X)

Key Stocks To Watch This Coming Week, The Unusual Suspects (ADP, CSX, FVE, GILD, LYV, LULU, RMBS, REGN, RIMM, SIRI, P, SIX, VRX)

The Week’s Largest Market Losers

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividends For Biotech? (AMGN, GILD)

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

Top Analyst Upgrades and Downgrades (ARG, IRE, BRCM, CPN, CELG, CIT, DRYS, GILD, INTC, LULU, MRVL, NVDA, PG, QCOM, RIMM, TXN)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026